Clinical performance assessment of five human papillomavirus DNA tests using liquid-based cytology samples

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 2, 2012, Pages 408-414

  Song, Seung Hun ^a   Hong, Jin Hwa ^b   Kwak, San Ha ^a   Lee, Jae Kwan ^a   Kim, Mi Kyung ^c  

^a Korea University College of Medicine   (South Korea)

^b School of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Genotyping; Human papillomavirus

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DNA MICROARRAY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84860847861     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01709.x     Document Type: Article

References (19)

1. Cuschieri KS, Cubie HA, Whitley MW et al. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 2005; 58: 946-950. (Pubitemid 41265279)
2. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19. (Pubitemid 29406813)
3. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999; 91: 506-511. (Pubitemid 29157058)
4. Lorincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 2003; 127: 959-968. (Pubitemid 36994855)
5. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172: 946-954.
6. Zielinski GD, Rozendaal L, Voorhorst FJ et al. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3. Gynecol Oncol 2003; 91: 67-73. (Pubitemid 37188595)
7. Gravitt PE, Peyton CL, Alessi TQ et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357-361. (Pubitemid 30043317)
8. An HJ, Cho NH, Lee SY et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2003; 97: 1672-1680. (Pubitemid 36355926)
9. Meijer CJ, Snijders PJ, Castle PE. Clinical utility of HPV genotyping. Gynecol Oncol 2006; 103: 12-17. (Pubitemid 44374721)
10. Castle PE, Porras C, Quint WG et al. Comparison of two PCRbased human papillomavirus genotyping methods. J Clin Microbiol 2008; 46: 3437-3445.
11. Cho NH, An HJ, Jeong JK et al. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: Comparison with cytologic diagnosis. Am J Obstet Gynecol 2003; 188: 56-62. (Pubitemid 36135598)
12. Lee GY, Kim SM, Rim SY, Choi HS, Park CS, Nam JH. Human papillomavirus (HPV) genotyping by HPV DNA chip in cervical cancer and precancerous lesions. Int J Gynecol Cancer 2005; 15: 81-87.
13. Stevens MP, Garland SM, Rudland E, Tan J, Quinn MA, Tabrizi SN. Comparison of the Digene Hybric Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol 2007; 45: 2130-2137. (Pubitemid 47203782)
14. Halfon P, Benmoura D, Khiri H et al. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck® HPV-screening assay. J Clin Virol 2010; 47: 38-42.
15. Lee JK, Kim MK, Song SH et al. Comparison of human papillomavirus detection and typing by hybrid capture 2, linear array, DNA chip, and cycle sequencing in cervical swab samples. Int J Gynecol Cancer 2009; 19: 266-272.
16. Coutlee F, Rouleau D, Petignat P et al. Enhanced detection and typing of human papillomavirus DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol 2006; 44: 1998-2006. (Pubitemid 43902145)
17. Vernon SD, Unger ER, Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 2000; 38: 651-655. (Pubitemid 30082658)
18. Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ, Bogers JJ. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 2007; 11: 881-891. (Pubitemid 47313308)
19. Lin CY, Chao A, Yang YC et al. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 2008; 42: 361-367.